Patient-centered Information on Permanent Contraception

February 29, 2024 updated by: University of California, San Francisco

Disseminating PCOR Findings to Reduce Racial Disparities in Surgical Sterilization

The goal of this study is to understand whether providing information to women with a strong desire to avoid future pregnancy about how tubal sterilization compares to long-acting reversible contraceptives improves perceived access to available contraceptives.

Participants will:

  • Complete a baseline survey
  • Receive access to web-based educational resources
  • Complete a brief follow up survey immediately after exploring these web-based resources
  • Complete a follow-up survey 3 months after enrolling

The investigators will compare outcomes among participants provided with access to a new website (intervention) summarizing recent patient-centered outcomes research (PCOR) comparing interval laparoscopic tubal sterilization and long-acting reversible contraception (LARC) to control participants provided with access to the existing Planned Parenthood website on tubal sterilization.

Study Overview

Detailed Description

This study evaluates the potential benefits of web-based resources to prepare patients considering tubal sterilization to effectively communicate their personal values and priorities to their clinicians, informed by recent patient centered outcomes research (PCOR) comparing interval tubal sterilization to long-acting reversible contraceptives. The investigators hypothesize that patients provided with information on the comparative safety and effectiveness of all available long acting contraceptives will be more likely to obtain contraceptive care that aligns with their personal preferences. The short-term goal of this work is to support patient-centered contraceptive care by increasing knowledge of and perceived access to all available long acting contraceptives among those who wish to avoid future pregnancy. The long-term goal of this work is to increase the proportion of women who are using a method of contraception that aligns with their personal preferences, reduce the proportion of women who regret having undergone a permanent contraceptive procedure, and reduce racial disparities in surgical sterilization.

Study Type

Interventional

Enrollment (Estimated)

350

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Self-reported fertility
  • Have a strong desire to avoid future pregnancy
  • Speak English or Spanish

Exclusion Criteria:

  • Current pregnancy
  • The inability to speak English or Spanish
  • Prior tubal sterilization or Essure procedure
  • Menopause
  • Infertility
  • Hysterectomy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Comparative information on tubal sterilization and other long-acting contraceptives
A new website comparing tubal sterilization to vasectomy and long-acting reversible contraceptives
A website comparing tubal sterilization to long-acting reversible contraceptives informed by recent patient centered outcomes research.
Other Names:
  • Comparisons of tubal sterilization to long-acting reversible contraceptives
Active Comparator: Information on tubal sterilization
Participants will be shown an existing web page developed by Planned Parenthood for people considering tubal sterilization
Information about tubal sterilization currently provided on the Planned Parenthood website

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perceived Access to Long Acting Contraceptives
Time Frame: Immediately after introduction to website and at 3 months follow-up
A 9-item, multi-dimensional measure assessing awareness, availability, accessibility, affordability, and acceptability of contraceptive options including tubal sterilization, vasectomy, the subdermal implant, hormonal IUD, and hormone-free IUD. A summative score ranging from 0 to 48 points will be calculated for each participant at baseline and follow up. We hypothesize there will be greater improvements from baseline to follow up in the intervention than control arm.
Immediately after introduction to website and at 3 months follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Person-Centered Contraceptive Counseling Measure
Time Frame: 3 month follow-up
4-items including: Letting me say what mattered to me about my birth control, Taking my preferences about my birth control seriously, Giving me enough information to make the best decision about my birth control method, Respecting me as a person, with responses range from 1 ("Strongly Disagree") to 5 ("Strongly Agree"). We hypothesize there will be greater improvements from baseline in the intervention than control arm.
3 month follow-up
Consumer Assessment of Healthcare Providers and Systems
Time Frame: 3 months follow-up

Response options on a 10-point Likert scale, ranging from poor (0) to excellent (10).

We hypothesize there will be greater improvements from baseline in the intervention than control arm.

3 months follow-up
Patients' Perceived Efficacy in Patient-Physician Interactions (PEPPI)
Time Frame: immediately after introduction to website and 3 months follow-up
To create a score on the 5 item contraceptive "PEPPI scale" ranging from 5 (lowest possible score) to 25 (representing highest patient-perceived self-efficacy), each item begins with "How confident are you in your ability to… ", and subjects respond to each question on a scale of 1 to 5, with 5 representing "very confident," and 1 representing "not at all confident" We hypothesize there will be greater improvements from baseline to follow up in the intervention than control arm.
immediately after introduction to website and 3 months follow-up
Knowledge of Long-Acting Contraceptives
Time Frame: Immediately after introduction to website and at 3 month follow-up
10 items adapted from the previously used Tubal Sterilization Knowledge Questionnaire items developed by Hall et al. Answers will be coded as correct vs. incorrect (with "Don't Know" being coded as an incorrect response) to create a knowledge score. We will calculate change in knowledge scores on follow up surveys compared to baseline. We hypothesize there will be greater improvements from baseline in the intervention than control arm.
Immediately after introduction to website and at 3 month follow-up
Use of preferred method of contraception
Time Frame: 3 month follow-up
3 items detailed in prior publication PMID 27710196
3 month follow-up
Would recommend website to a friend
Time Frame: Immediately after introduction to website, and at 3 month follow up
5 items designed to evaluate usability of website and recommendations to friends. E.g., "Using a scale of 0 (not at all) to 10 (extremely likely), participants will indicate how likely they are to recommend this website to a friend who is considering getting her tubes tied? (0-10)"
Immediately after introduction to website, and at 3 month follow up

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Suggestions for how to improve web-based resources for people considering permanent contraception.
Time Frame: immediately following introduction to website and at 3 months follow-up
Open-ended question regarding ease-of-use and helpfulness of the web-based program. These responses will provide ongoing information to help guide future adaptations and dissemination.
immediately following introduction to website and at 3 months follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Eleanor Schwarz, MD, MS, University of California, San Francisco

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 1, 2024

Primary Completion (Estimated)

April 1, 2025

Study Completion (Estimated)

April 1, 2025

Study Registration Dates

First Submitted

January 2, 2024

First Submitted That Met QC Criteria

February 29, 2024

First Posted (Actual)

March 6, 2024

Study Record Updates

Last Update Posted (Actual)

March 6, 2024

Last Update Submitted That Met QC Criteria

February 29, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 5R18HS029432-02 (U.S. AHRQ Grant/Contract)
  • R18HS029432 (U.S. AHRQ Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Contraception

Clinical Trials on Advancing Access Website

3
Subscribe